Mini binders,
big impact

Minibinders are small, stable, and highly modular, offering incredible opportunity for new therapeutics. Unlocking their full potential requires going beyond what today’s frontier AI models can design.
Get in touch

Proprietary scaffolds

We begin beyond the training set of existing AI models. Based on natural scaffolds with incredible properties, our binders are unreachable by other methods.

Trillions of data points

Our data generation platform explores vast functional design space, enabling design of highly translatable, exquisitely targeted binders.

From sequence to function

Our models learn from biological function, generating minibinder sequences with amazing properties.

Moab is building minibinders with big therapeutic impact. Through a combination of novel scaffolds, ultra high throughput data generation, and advanced AI models, they are exploring protein design space beyond the reach of other methods. Based in Berkeley, CA, and funded by SciFounders and Compound VC, Moab is advancing a pipeline of potent binders and enabling partners to design incredible therapeutics.